Christopher Paul Simms

Senior Vice President, CCO, IVERIC bio.

Companies

4D Molecular Therapeutics, Inc.Officer Dec 19, 2025 to now¹
IVERIC bioSenior Vice President, CCO Aug 4, 2021 to Jul 13, 2023²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

IVERIC bio0 shares³Jul 11, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

Jul 11, 2023Returned to company 32,429 shares of IVERIC bio³
Jan 3, 2023Sold 2,368 shares at $20.06 of IVERIC bio⁴
Jan 2, 2023Exercised options 6,250 shares of IVERIC bio⁴
Aug 3, 2022Sold 6,818 shares at $11.25 of IVERIC bio⁵
Aug 3, 2022Sold 5,454 shares at $11.25 of IVERIC bio⁵
Aug 2, 2022Exercised options 18,750 shares of IVERIC bio⁵
Aug 2, 2022Exercised options 15,000 shares of IVERIC bio⁵
Nov 18, 2021Bought 3,069 shares at $16.30 of IVERIC bio⁶

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGAR4D Molecular Therapeutics, Inc., Officer
2
SEC EDGARIVERIC bio, Senior Vice President, CCO
3
SEC EDGARIVERIC bio shares after the filing of Jul 11, 2023
4
SEC EDGARForm 4 filed Jan 4, 2023
5
SEC EDGARForm 4 filed Aug 4, 2022
6
SEC EDGARForm 4 filed Nov 22, 2021